MedPath

SEMS Placement Followed by Chemotherapy and Surgery for Obstructing Left-sided Colonic Cancer

Completed
Conditions
Complication of Treatment
Registration Number
NCT04039360
Lead Sponsor
Beijing Chao Yang Hospital
Brief Summary

This study aimed to evaluate the safety and feasibility of SEMS followed by neoadjuvant chemotherapy prior to elective surgery for obstructing left-sided colon cancer.

Detailed Description

Stoma is reported to be frequent in self-expanding metallic stent (SEMS) treated patients with obstructing left-sided colon cancer than in those with non-obstructing surgery. Retrospective study reported worse overall survival with SEMS and elective surgery than with emergency surgery in patients with left-sided malignant colon obstruction. In practice, intestinal wall edema following stent placement increases the difficulty of surgery, and this could be a major problem if the interval between stent insertion and surgery is short (1-2 weeks). The patients with obstructing left-sided colon cancer received SEMS treatment, and the recevied neoadjuvant chemotherapy prior to elective surgery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
11
Inclusion Criteria
  1. histologically proven adenocarcinoma located in the left colon (between the splenic flexure and 15 cm proximal to the anal margin)
  2. Eastern Cooperative Oncology Group (ECOG) performance status of from 0 to 2
Exclusion Criteria
  1. history of any other cancer
  2. multiple primary colorectal cancers
  3. distant metastases
  4. hereditary nonpolyposis colorectal cancer
  5. familial adenomatous polyposis

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
stoma rate3 years after operation

stoma rate after surgery

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath